UNITED STATES

SECURITIES AND EXCHANGE COMMISSION  

Washington, D.C. 20549

Form 8-K

Current Report

Pursuant to Section 13 or 15(d) of the  

Securities Exchange Act of 1934

August 5, 2021

Date of Report (Date of earliest event reported)

Williams Rowland Acquisition Corp.

(Exact Name of Registrant as Specified in its Charter)

Registrant’s telephone number, including area code: (203) 353-7610

N/A

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Securities registered pursuant to Section 12(b) of the Act:

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 8.01. Other Events

As previously disclosed on a Current Report on Form 8-K filed on August 4, 2021 (the “Current Report”), on July 29, 2021, Williams Rowland Acquisition Corp. (the “Company”) consummated its initial public offering (the “IPO”) of 20,000,000 units (the “Units”), each Unit consisting of one share of common stock of the Company, par value $0.0001 per share (the “Common Stock”) and one-half of one redeemable warrant (“Warrant”), each whole Warrant entitling the holder thereof to purchase one share of Common Stock for $11.50 per share. The Units were sold at a price of $10.00 per Unit, generating gross proceeds to the Company of $200,000,000.

As previously disclosed in the Current Report, simultaneously with the closing of the IPO, the two sponsor entities of the Company purchased in a private placement (the “Private Placement”) an aggregate of 9,900,000 warrants at a per warrant price of $1.00 for total consideration of $9,900,000.

As previously disclosed in the Current Report, on August 3, 2021, the underwriter announced its intention to exercise its overallotment option to purchase an additional 3,000,000 Units (the “Over-Allotment Units”). The sale of the Over-Allotment Units closed on August 5, 2021 generating gross proceeds of $30,000,000. Simultaneous with the sale of the Over-Allotment Units, the Company consummated a private sale of 1,200,000 warrants, generating gross proceeds of $1,200,000.

As of August 5, 2021, a total of $234,600,000 of the net proceeds from the IPO and the Private Placements was deposited in a trust account established for the benefit of the Company’s public stockholders with Continental Stock Transfer & Trust Company acting as trustee.

  An unaudited pro forma balance sheet as of July 29, 2021 reflecting receipt of the proceeds from the Over-Allotment Units and the second Private Placement is included with this report as Exhibit 99.1

Item 9.01. Financial Statements and Exhibits.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.